China Literature (772) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
7 Aug, 2026Executive summary
Revenue declined 9.3% year-over-year to RMB 7,366.2 million, with gross profit down 13.4% to RMB 3,396.8 million and net loss to shareholders widening to RMB 776 million, mainly due to a RMB 1.8 billion goodwill impairment.
Non-IFRS net profit attributable to shareholders dropped 24.8% to RMB 858.5 million.
Online business revenue remained stable, while IP operations and others saw a significant decline.
The company leveraged its deep IP library and creator ecosystem to deliver hit content across multiple formats.
No dividend was declared for the year.
Financial highlights
Total revenues were RMB 7.37 billion, down from RMB 8.12 billion in 2024.
Online business revenues were RMB 4.05 billion, up 0.4% year-over-year.
IP operations and other revenues were RMB 3.32 billion, down 18.9%, mainly due to fewer drama and film releases.
Gross profit was RMB 3.4 billion, with a gross margin of 46.1% (down from 48.3%).
Adjusted EBITDA dropped 33.5% to RMB 614 million, with margin at 8.3%.
Outlook and guidance
Plans to release at least 200 short dramas in 2026, aiming for further growth in hit rate and profitability.
Focus on scaling AI-animated drama business and expanding premium content offerings.
Continued global expansion leveraging AI translation and international partnerships.
Emphasis on diversifying content genres and strengthening the IP merchandise ecosystem.
Management anticipates sustainable long-term growth through the “IP + AI” ecosystem.
Latest events from China Literature
- Revenue up 10.7% as IP and merchandise surged, but profit fell sharply due to tax charge.772
H1 2026 - Operating profit nearly doubled despite revenue drop, driven by cost controls and asset gains.772
H1 2025 - Revenue up 27.7% and net profit up 33.9% YoY, led by blockbuster IP and global expansion.772
H1 2024 - Revenue up 15.8% to RMB8.1B, strong IP and AI growth, but goodwill impairment led to net loss.772
H2 2024